Processa Pharmaceuticals (PCSA) Expected to Announce Earnings on Friday

Processa Pharmaceuticals (NASDAQ:PCSA) is expected to announce its Q1 2025 earnings results before the market opens on Friday, May 9th. Analysts expect Processa Pharmaceuticals to post earnings of ($0.77) per share for the quarter.

Processa Pharmaceuticals (NASDAQ:PCSA) last issued its quarterly earnings results on Thursday, March 20th. The company reported ($0.74) EPS for the quarter, topping analysts’ consensus estimates of ($0.92) by $0.18. On average, analysts expect Processa Pharmaceuticals to post $-4 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Processa Pharmaceuticals Price Performance

NASDAQ:PCSA opened at $0.26 on Thursday. The stock has a market cap of $1.36 million, a P/E ratio of -0.08 and a beta of 1.36. The company has a fifty day moving average price of $0.34 and a 200 day moving average price of $0.71. Processa Pharmaceuticals has a one year low of $0.15 and a one year high of $3.10.

About Processa Pharmaceuticals

Processa Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells.